The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of phase II randomized study of intermittent versus continuous schedule of vemurafenib plus cobimetinib in BRAF-mutated advanced melanoma.
 
Maria Gonzalez-Cao
Honoraria - BMS Brazil; MSD; Pierre Fabre; Roche Belgium; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Roche
Research Funding - AstraZeneca; Roche
 
Clara Mayo de las Casas
Employment - Pangaea Oncology
 
Juana Oramas
No Relationships to Disclose
 
Miguel-Angel Berciano-Guerrero
No Relationships to Disclose
 
Luis De la Cruz
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
Research Funding - Celgene (Inst); Celgene (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Pablo Cerezuela-Fuentes
Consulting or Advisory Role - Novartis; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis; Rovi; Sanofi/Regeneron
Travel, Accommodations, Expenses - Merck; Novartis; Roche
 
Ana Maria Arance
Consulting or Advisory Role - Amgen; BMSi; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; BMSi; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Research Funding - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Amgen; BMSi; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
 
Eva Muñoz-Couselo
No Relationships to Disclose
 
Enrique Espinosa
Honoraria - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - MSD Oncology
Research Funding - Roche (I)
Travel, Accommodations, Expenses - MSD Oncology
 
Teresa Puértolas
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche/Genentech
Travel, Accommodations, Expenses - Roche
 
Robert Diaz Beveridge
No Relationships to Disclose
 
Sebastian Ochenduszko
No Relationships to Disclose
 
Maria Jose Villanueva Silva
No Relationships to Disclose
 
Laura Basterretxea
No Relationships to Disclose
 
Lorena Bellido
No Relationships to Disclose
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - AstraZeneca Spain; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Ana Drozdowskyj
Employment - Jhonson&Jhonson (I)
Honoraria - Jhonson&Jhonson (I)
 
Miguel Angel Molina Vila
Employment - Pangaea Oncology
Research Funding - AstraZeneca (Inst); In3Bio (Inst); Merck Serono (Inst)
 
Jose Antonio Lopez-Martin
No Relationships to Disclose
 
Alfonso Berrocal
Honoraria - Amgen; BMS; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
Consulting or Advisory Role - BMS; Merck; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech
Travel, Accommodations, Expenses - BMS; MSD